R&D Magazine recently honored synthetic polymer Chemist Kevin N. Sill, co-founder and chief scientific officer of Intenzyne, with the Young Innovator of the Year award. The magazine's newest honor, it awards individuals under the age of 31 who are making a significant contribution to society through science.
Founded four years ago by Sill and Habib Skaff, Itenzyme develops pharmaceutical products for use in cancer treatment. The company developed the IVECT Method, which is a multifaceted approach to treating tumors. Intezyne is located at the University of South Florida's
Tampa Bay Technology Incubator.
Read the complete
news release.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.